Nexcida Therapeutics

Next-generation antibiotics for drug-resistant bacteria

Nexcida is developing novel antibiotics to treat serious, life-threatening bacterial infections. The company is led by an outstanding team of proven anti-infectives drug developers and is committed to addressing the emerging threat of drug-resistant bacteria.

Year of Investment
2015
Strategy
Life Sciences
Location
Bay Area, California